Concepedia

Jiejun Wang

JW

Statistics

Publications

55

Citations

8.4K

H-Index

27

Active since

2005

Affiliations

Second Military Medical University(Current)

Shanghai Changzheng Hospital

Changhai Hospital

University of Electronic Science and Technology of China

Capital Medical University

Jiejun Wang is an author at Second Military Medical University specializing in medicine, oncology, and molecular oncology.

Publications per year

2005–2024

55

Publications

55

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen et al. · The Lancet Oncology · 2008 · 5.8K citations

Medicine, Oncology, Pharmacotherapy +11

Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer

Jin Li, Shukui Qin, Rui‐Hua Xu et al. · JAMA · 2018 · 404 citations · Full text

Medicine, Oncology, Pharmacology +17

Overexpression of Phosphorylated Mammalian Target of Rapamycin Predicts Lymph Node Metastasis and Prognosis of Chinese Patients with Gastric Cancer

Guanzhen Yu, Jiejun Wang, Ying Chen et al. · Clinical Cancer Research · 2009 · 164 citations

Medicine, Cancer Biology, Oncology +16

[Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients].

Jinwan Wang, Yan Sun, Qitao Yu et al. · PubMed · 2005 · 147 citations

Medicine, Oncology, Pharmacology +13

MicroRNA‐155 is a novel suppressor of ovarian cancer‐initiating cells that targets CLDN1

Wenxing Qin, Qiusheng Ren, Te Liu et al. · FEBS Letters · 2013 · 137 citations

Medicine, Cancer Biology, Oncology +17

1–5 of 55